Ophthalmic Viscoelastic Devices (OVD) Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

The global ophthalmic viscoelastic devices (OVD) market was valued at USD 2.96 billion in 2025. It is poised to grow at a CAGR of 4.10% during the forecast period of 2026-2035, and reach USD 4.43 billion by 2035. The market growth is driven by the rising prevalence of cataract and glaucoma, expanding geriatric population, increasing diabetes prevalence, and growing demand for premium intraocular lens implantation procedures globally.

Latest News on the Ophthalmic Viscoelastic Devices (OVD) Market (2026)

• In March 2026, Johnson & Johnson received FDA approval for the TECNIS PureSee extended-depth-of-focus IOL for cataract surgery, with the device's directions for use specifying that the HEALON family of OVDs is required for optimal performance, directly reinforcing OVD demand.
• In October 2025, Rayner Intraocular Lenses Limited secured U.S. Food and Drug Administration approval for RayOne EMV Toric IOL, advancing premium toric cataract surgery and associated surgical device adoption.
• As per the American Academy of Ophthalmology, over 10 million cataract surgeries are performed each year worldwide, with cataracts affecting approximately 65.2 million people, significantly accelerating demand for OVDs in anterior segment procedures.

Key Market Trends and Insights

• Based on type, the dispersive OVDs segment held over 37% revenue share in the historical period.
• Based on application, cataract surgery accounted for above 50% share of the market in the historical period.
• Based on region, North America accounted for about 38% revenue share in the historical period.

Market Size and Forecast

• Market Size 2025: USD 2.96 billion
• Projected Market Size in 2035: USD 4.43 billion
• CAGR from 2026-2035: 4.10 %

Ophthalmic Viscoelastic Devices (OVD) Market Overview

The market reached a value of approximately USD 2.96 billion in 2025. The market is anticipated to witness consistent expansion, driven by a rising CAGR over the forecast period, supported by rising cataract surgery volumes, the increasing geriatric population, and surging demand for premium intraocular lenses. The shift toward viscoadaptive and combination OVD packaging is accelerating procedural efficiency. Integration with broader ophthalmic surgicaldevices ecosystems and innovations in semi-synthetic and viscoadaptive formulations are further strengthening growth. Additionally, the rising diabetes prevalence and growing minimally invasive glaucoma surgery (MIGS) volumes are pushing utilization. Increasing investments by leading players in dual-pack and prefilled syringe formats, alongside broader expansion across the ophthalmic devices landscape, are expected to sustain long-term market expansion.

Ophthalmic Viscoelastic Devices (OVD) Market Segmentation

Market Breakup by Type

• Cohesive OVDs
• Dispersive OVDs
• Viscoadaptive OVDs

The market is segmented into cohesive OVDs, dispersive OVDs, and viscoadaptive OVDs based on type. Dispersive OVDs are expected to account for a significant market share owing to their enhanced ability to protect corneal endothelial cells during cataract surgery and phacoemulsification procedures. Meanwhile, cohesive OVDs are witnessing increasing adoption for maintaining anterior chamber stability and supporting intraocular lens implantation. Rising demand for minimally invasive ophthalmic procedures and advanced surgical solutions is further driving market growth.

Market Breakup by Application

• Cataract Surgery
• Glaucoma Surgery
• Corneal Transplantation
• Vitreoretinal Surgery

The market spans cataract surgery, glaucoma surgery, corneal transplant, and vitreoretinal surgery. Cataract surgery is likely to lead to high global procedure volumes, while vitreoretinal applications continue expanding rapidly with rising diabetic retinopathy prevalence. Increasing clinical evidence is strengthening the importance of intraocular lens implantation workflows across all indications.

Market Breakup by End Users

• Hospitals
• Ophthalmic Clinics
• Ambulatory Surgical Centers
• Others

The ophthalmic viscoelastic devices (OVD) market is segmented into hospitals, ophthalmic clinics, ambulatory surgical centers, and others. Hospitals are anticipated to dominate the market owing to the increasing volume of ophthalmic procedures and the availability of advanced surgical infrastructure. Meanwhile, ophthalmic clinics and ambulatory surgical centers are witnessing steady growth due to the rising demand for minimally invasive surgery, faster patient turnaround times, and the growing preference for specialized outpatient eye care services.

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate due to advanced ophthalmic care infrastructure, a large geriatric population, and strong reimbursement frameworks, while Europe maintains steady growth. Asia Pacific is expected to expand rapidly, supported by improving access to eye care services and rising healthcare expenditure.

Ophthalmic Viscoelastic Devices (OVD) Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

Over 10 million cataract surgeries performed annually worldwide, sustaining strong OVD demand across anterior segment procedures

Market Restraints

Adoption of low-OVD or OVD-free fluidics techniques in advanced phacoemulsification systems

Modern fluidics platforms reduce viscoelastic volume per case, moderating premium OVD demand growth in mature markets

Market Opportunities

Expansion of viscoadaptive and dual-pack OVD formulations for complex surgeries

Ophthalmic Viscoelastic Devices (OVD) Market Dynamics

This section analyzes key factors influencing market growth, including rising cataract and glaucoma surgical volumes, technological substitution from low-OVD fluidics, evolving premium IOL adoption, and competitive product launches, while integrating interlinking keywords to highlight ecosystem-wide industry connections.

Ophthalmic Viscoelastic Devices (OVD) Market Drivers

Premium IOL Adoption and Cataract Surgery Growth Driving the Market Demand

The expanding adoption of premium presbyopia-correcting and extended depth of focus intraocular lenses is a major driver of OVD market growth, supported by rising cataract surgery volumes and growing patient demand for spectacle independence. For instance, in March 2026, Johnson & Johnson received FDA approval for the TECNIS PureSee EDOF intraocular lens, with the device's directions for use specifying that the HEALON family of OVDs is required for optimal performance during implantation. These integrated workflows enhance surgical precision and patient outcomes, thereby driving market growth during the forecast period, with strong synergies extending to the broader intraocular lens segment globally.

Ophthalmic Viscoelastic Devices (OVD) Market Restraints

Advancements in Low-OVD Surgical Technologies Limiting Conventional OVD Adoption

The introduction of low-OVD or OVD-free surgical techniques remains a significant restraint for ophthalmic viscoelastic devices, particularly in mature high-income markets. Modern phacoemulsification fluidics platforms stabilize the anterior chamber with balanced salt solution, reducing viscoelastic volume per case. Manufacturers are responding through the development of viscoadaptive single-syringe formulations, sorbitol-enhanced free-radical protection, and prefilled syringe formats, which are improving clinical value and supporting sustained adoption across the market during the forecast period.

Ophthalmic Viscoelastic Devices (OVD) Market Opportunities

Dual-Action and Sorbitol-Enhanced OVD Innovation Creating Opportunities

Continuous innovation in premium toric IOL platforms and dual-action OVD formulations is creating strong growth opportunities, supported by rising surgical safety expectations and growing premium-IOL adoption. For instance, in October 2025, Rayner Intraocular Lenses Limited received FDA approval for its RayOne EMV Toric intraocular lens following a successful pivotal Investigational Device Exemption (IDE) study, expanding the premium toric cataract surgical environment in which advanced viscoelastic devices are deployed for endothelial protection and anterior chamber maintenance during IOL implantation. These advancements enhance clinical safety and surgical efficiency, driving recurring demand and strengthening growth prospects across the cataract surgery devices landscape, reinforcing demand across the cataract surgery device segment.

Ophthalmic Viscoelastic Devices (OVD) Market Trends

Viscoadaptive Formulation Adoption and Premium Surgical Platform Expansion Shaping Market Evolution

The growing adoption of viscoadaptive OVD formulations alongside next-generation cataract surgical platforms is a key trend shaping the market, supported by rising complex cataract and premium IOL surgery volumes. For instance, in February 2026, Alcon confirmed during its Q4 2025 earnings call that UNITY VCS had been introduced across most major markets worldwide and that UNITY CS rollout would continue expanding global availability throughout 2026, broadening the surgical platform footprint in which premium viscoelastic devices are deployed. The trend is set to strengthen the ophthalmic surgery market during the forecast period, supported by parallel demand growth across the broader eye care landscape.

Ophthalmic Viscoelastic Devices (OVD) Market Share

Dispersive OVD Segment Likely to Dominate the Market Share by Product

The dispersive OVD segment dominated the market with approximately 37% revenue share in the historical period, driven by its superior corneal endothelial protection during cataract surgery. Dispersive OVDs create a stable viscoelastic environment that helps maintain intraocular pressure and protects delicate tissues. Continuous innovation in sodium hyaluronate and chondroitin sulfate formulations supports clinical reliability. Furthermore, growing synergy with phacoemulsification workflows further reinforces clinical adoption and operational efficiency.

Ophthalmic Viscoelastic Devices (OVD) Market Analysis by Region

North America is likely to dominate the market as it accounted for about 37% market share in the historical period, supported by a significant population with cataract and glaucoma disorders, robust healthcare infrastructure, and increasing R&D investments by key players. The United States market leads regional growth due to its large geriatric population and extensive healthcare coverage. Additionally, growing integration with medicare reimbursement frameworks, rising premium IOL adoption and growing procedural integration with the ophthalmic diagnostic devices segment further support steady market growth during the forecast period.

Leading Players in the Ophthalmic Viscoelastic Devices (OVD) Market

Johnson & Johnson MedTech

Founded in 1886 and headquartered in New Brunswick, New Jersey, USA, Johnson & Johnson MedTech offers a broad ophthalmology portfolio in the ophthalmic viscoelastic devices market, including surgical systems, intraocular lenses, and vision care technologies. The company supports advanced eye surgery procedures through its innovative ophthalmic solutions designed to enhance surgical precision and patient outcomes globally.

Bausch + Lomb corporation

Headquartered in Vaughan, Ontario, Canada, the company was established in 1853 and is a global leader in eye health products. Its OVD portfolio includes StableVisc, ClearVisc, and the TotalVisc Viscoelastic System launched in the United States in April 2023. The company plays a significant role in the cataract surgery segment through innovative dual-action and sorbitol-enhanced viscoelastic formulations.

Alcon Inc.

Founded in 1945 and headquartered in Geneva, Switzerland, Alcon Inc. specializes in ophthalmic surgical equipment, viscoelastic solutions, intraocular lenses, and eye care products. The company plays a significant role in advancing ophthalmic devices through innovative technologies that improve procedural efficiency, surgical safety, and visual outcomes across global healthcare facilities.

Rayner Surgical Group Limited

Established in 1910 and headquartered in Worthing, United Kingdom, Rayner Surgical Group Limited focuses on intraocular lenses, ophthalmic viscoelastic products, and surgical devices for ophthalmology procedures. The company is recognized for supporting modern ocular healthcare with premium eye surgery technologies and expanding product innovations aimed at enhancing clinical performance and patient care standards worldwide.

Other key players are Nordic Pharma, Inc., Eyekon Medical Inc., Shanghai Haohai Biological Technology Co., Ltd., Rumex International Co., Beaver-Visitec International Holdings, Inc. and Carl Zeiss Meditec AG

Key Questions Answered in the Ophthalmic Viscoelastic Devices (OVD) Market Report

• What was the ophthalmic viscoelastic devices (OVD) market value in 2025?
• What is the OVD market forecast outlook for 2026-2035?
• What major factors aid the demand for the OVD market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major OVD market trends?
• Which type is expected to dominate the market segment?
• Which application is expected to dominate the market segment?
• Which end users is expected to dominate the market segment?
• Who are the key players in the OVD market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?